Spectrascience New Stock Probability of Future Stock Price Finishing Under 0.0
Spectrascience New's future price is the expected price of Spectrascience New instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Spectrascience New performance during a given time horizon utilizing its historical volatility. Check out Spectrascience New Backtesting, Spectrascience New Valuation, Spectrascience New Correlation, Spectrascience New Hype Analysis, Spectrascience New Volatility, Spectrascience New History as well as Spectrascience New Performance. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.
As of December 1, 2024, Price To Sales Ratio is expected to decline to 196.50. In addition to that, Price Earnings Ratio is expected to decline to -0.25. Please specify Spectrascience New's target price for which you would like Spectrascience New odds to be computed.
Spectrascience |
Spectrascience New Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Spectrascience New for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Spectrascience New can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Spectrascience New generated a negative expected return over the last 90 days | |
| Spectrascience New has some characteristics of a very speculative penny stock | |
| Spectrascience New has high likelihood to experience some financial distress in the next 2 years | |
| Spectrascience New currently holds 6.38 M in liabilities. Spectrascience New has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Spectrascience New's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 5.15 K. Net Loss for the year was (4.47 M) with loss before overhead, payroll, taxes, and interest of (194.25 K). | |
| Spectrascience New currently holds about 27.88 K in cash with (1.51 M) of positive cash flow from operations. | |
| Spectrascience New has a frail financial position based on the latest SEC disclosures |
Spectrascience New Technical Analysis
Spectrascience New's future price can be derived by breaking down and analyzing its technical indicators over time. Spectrascience Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Spectrascience New. In general, you should focus on analyzing Spectrascience Stock price patterns and their correlations with different microeconomic environments and drivers.
Spectrascience New Predictive Forecast Models
Spectrascience New's time-series forecasting models is one of many Spectrascience New's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Spectrascience New's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Spectrascience New
Checking the ongoing alerts about Spectrascience New for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Spectrascience New help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Spectrascience New generated a negative expected return over the last 90 days | |
| Spectrascience New has some characteristics of a very speculative penny stock | |
| Spectrascience New has high likelihood to experience some financial distress in the next 2 years | |
| Spectrascience New currently holds 6.38 M in liabilities. Spectrascience New has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Spectrascience New's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 5.15 K. Net Loss for the year was (4.47 M) with loss before overhead, payroll, taxes, and interest of (194.25 K). | |
| Spectrascience New currently holds about 27.88 K in cash with (1.51 M) of positive cash flow from operations. | |
| Spectrascience New has a frail financial position based on the latest SEC disclosures |
Check out Spectrascience New Backtesting, Spectrascience New Valuation, Spectrascience New Correlation, Spectrascience New Hype Analysis, Spectrascience New Volatility, Spectrascience New History as well as Spectrascience New Performance. For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.01) | Return On Assets (0.92) |
The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.